Sinovac Biotech Ltd. (SVA) Posts Mixed Q3 Results; Reaffirms Outlook

November 15, 2010 8:02 AM EST
Get Alerts SVA Hot Sheet
Trade SVA Now!
Join SI Premium – FREE
Sinovac Biotech Ltd. (NYS: SVA) reports Q3 loss of $0.01, versus the analyst estimate of $0.02. Revenue for the quarter came in at $9.55 million, versus the consensus estimate of $9.53 million.

Reaffirms FY10 outlook.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Add Your Comment